Use our chat feature to speak with one of our expert consultants who can help you identify if medical cannabis can help you.
7 min read
Sarah Sinclair
Because they affect around one in seven people, Migraine Awareness Week is a crucial initiative to spotlight the significant impact migraines have on millions of lives worldwide. With conventional treatments not always able to provide adequate relief, medical cannabis has emerged as a promising alternative.
We take a look at how medical cannabis may offer a new avenue of hope for those living with migraine.
Migraine Awareness Week takes place from 23-29 September 2024. It is an initiative led by The Migraine Trust to raise awareness of the condition and highlight its impact on the millions of people affected around the world.
According to the Migraine Trust, migraine is the third most common disease in the world, affecting over a billion people globally and over 10 million in the UK.
Despite often being dismissed as ‘just a headache’, migraine is a complex neurological disorder, which can have a significant impact on an individual’s quality of life, impacting their mental health, relationships, education and ability to work.
According to the NHS, migraines usually last between two hours and three days, with some symptoms (such as feeling very tired) starting up to 2 days before the head pain starts and finishing after the headache stops.
There are several subtypes, each characterised by distinct symptoms and triggers.
The three main types of migraine are:
Symptoms include throbbing or pulsating headache, usually on one side of the head, lasting four to 72 hours. It may be accompanied by nausea, vomiting, and sensitivity to light, sound, or smells.
Symptoms include visual disturbances (such as flashing lights or zigzag patterns), sensory changes (like tingling or numbness), or speech/language difficulties that precede the headache phase.
Symptoms include headaches occurring on 15 or more days per month for more than three months, with at least eight of these headaches being migraines.
Other, less-common types of migraine include: Migraine with Brainstem Aura (Basilar-Type Migraine), Hemiplegic Migraine, Retinal (Ocular) Migraine, Vestibular Migraine, Menstrual Migraine, Abdominal Migraine, Status Migrainosus.
The cause of migraine pain isn’t known, but you are more likely to experience them if you have a family history.
Some people find they have certain triggers such as:
Migraine treatment varies, with each type requiring different management strategies.
Common treatments include:
Your GP may also recommend making changes to your lifestyle to help manage your migraines, such as eating at regular times and drinking less caffeine.
If these treatments don’t work, you may be offered a new type of medicine by the NHS called a gepant, which works in a different way to other migraine medicines.
Gepants are injectable calcitonin gene-related peptide (CGRP) antagonists which bind to that CGRP receptor on the trigeminal nerve and block it from being released.
Early indications suggest that gepants may be the first acute treatment not associated with medication overuse headaches, and may also be used as a preventive measure. There are currently two types of Gepant medications available on the NHS.
Many patients report migraine relief with medical cannabis, and it is increasingly being explored as a potential new treatment option.
Experts believe that cannabinoids such as CBD and THC may have benefits due to how they interact with the endocannabinoid system, which plays a role in pain regulation. Alongside this it could have a preventative effect through suppressing the abnormal wave of voltage depression in the brain’s cortical neurons, which precedes all migraine attacks.
As well as pain relief and a reduction in frequency, cannabis has (anti-nausea) properties, which can be particularly helpful for migraines accompanied by severe nausea and vomiting.
It can also help promote relaxation and improve sleep, which can be beneficial since sleep disturbances and stress are common migraine triggers.
While more research is needed on the role of medical cannabis in managing headaches and migraines, a literature review concluded that the data is “encouraging”, with “beneficial long-term and short-term effects”.
One study published in the Journal of Pain in 2019 found that inhaled cannabis could reduce migraine severity by almost 50%. Cannabis reduced migraine severity regardless of the type, dose, THC, or CBD content, however, reductions in headache severity were significantly greater with concentrates than with flowers.
A separate cross-sectional trial investigated the association between medical cannabis treatment and migraine frequency. Those who used cannabis reported lower current migraine disability, less negative headache impact, lower rates of opioid and migraine medication (triptans) consumption, and improved sleep compared to those who didn’t.
However, it’s also important to consider the possible risks and side-effects of medical cannabis for migraines. Like a lot of other treatments, some migraine sufferers report significant relief with medical cannabis, but some others may find little benefit or experience adverse effects. Medical cannabis is not a one-size fits all solution.
For some individuals, cannabis use may lead to increased anxiety or paranoia, which may worsen migraine symptoms. One study also suggested that cannabis could lead to ‘rebound’ headaches in patients living with chronic migraine.
‘Rebound’ headache, also known as medication overuse headache, occurs when pain medication is overused by patients who have an underlying primary headache disorder such as migraine. The research found that those using cannabis were six times more likely to have medication overuse headaches than those who did not use cannabis.
In a word: yes. Medical cannabis is prescribed in the UK by specialist doctors for chronic pain related to migraine. Due to variability in response and potential side effects, it should be considered carefully and under the guidance of a clinician.
If you think you may benefit from treatment with medical cannabis you can use Releaf’s free eligibility checker to determine if it’s right for you. If appropriate you will be invited to schedule an appointment with a specialist consultant.
You can find out more about medical cannabis via the FAQs page or by contacting a member of the team. As always, never make any changes to your treatment plan without consulting a doctor first.
It is important to seek medical advice before starting any new treatments. The patient advisors at Releaf are available to provide expert advice and support. Alternatively, click here to book a consultation with one of our specialist doctors.
Get comprehensive care, convenience, and confidence with an all-in-one treatment plan.
Am I eligible?Sarah, a distinguished journalist with over a decade in publishing and communications, now excels in cannabis health and policy journalism in the UK, advocating for informed health decisions through her award-winning work.
All of our articles are written by medical cannabis experts, guided by strict sourcing guidelines, and reference peer-reviewed studies and credible academic research. Our expert clinical team and compliance specialists provide valuable insights to ensure accuracy when required. Learn more in our editorial policy.
Need more help?
With extended families coming together and immediate families typically spending long periods of time together over the Christmas period, catching up on what everyone has been up to over the last year is a common course conversation takes.
Lucy MacKinnon
With UK medical cannabis going nothing short of viral in the past 12 months or so (and patient numbers climbing at an exponential rate), the need for clear, concise information regarding medical cannabis accessories has never been more obvious.
Sam North
Growing awareness and acceptance of cannabis-based products has been on the rise in recent years. In addition to a flourishing CBD consumer market, medical cannabis has become increasingly accessible to patients with a variety of health concerns.
Emily Ledger
